Brightgene Bio-medical Technology Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ARGATROBAN, with a corresponding US DMF Number 35491.
Remarkably, this DMF maintains an Active status since its submission on December 26, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 01, 2021, and payment made on April 14, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II